Ultrasound Guided Retroclavicular Infraclavicular Versus Axillary Block as Regional Anesthesia in Obese Patients
1 other identifier
interventional
90
1 country
1
Brief Summary
The purpose of this study is to compare the analgesic outcomes (time to first analgesic request, total amount of analgesic consumption, and pain scores) following the ultrasound-guided retroclavicular infraclavicular approach and the axillary approach in obese patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2025
CompletedFirst Posted
Study publicly available on registry
October 7, 2025
CompletedStudy Start
First participant enrolled
October 15, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 15, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
April 15, 2026
CompletedDecember 16, 2025
September 1, 2025
5 months
September 30, 2025
December 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to first analgesic request in each group
24 hours postoperative
Secondary Outcomes (9)
Block assessment and definition of successful block
30 minutes after the block
Imaging time
the time between probe application and insertion of the needle
Needle time
the time between insertion of the needle and complete injection of local anesthetic
-Procedure time
the summation of the imaging and needling times
Pain intensity
basal, one, 2, 4, 8, 12, 16, 20 and 24 hours postoperative
- +4 more secondary outcomes
Study Arms (2)
Group (R)
ACTIVE COMPARATORPatients will recieve retroclavicular infraclavicular brachial plexus block
Group (A)
ACTIVE COMPARATORPatients will receive the axillary brachial plexus
Interventions
The patient will be placed supine, head facing the contralateral side. A high- frequency 13-6 MHz linear array transducer probe will be placed medial to the coracoid process below and perpendicular to the clavicle to obtain a short-axis view of the cords of the brachial plexus and the axillary vessels. The needle will be inserted in the supraclavicular fossa, approximately one cm posteriorly to the clavicle, and advanced in plane parallel to the probe. After passing the initial blind zone of about 2 cm caused by the clavicle's acoustic shadow, the needle tip will be continuously seen, until it appears posterior to the axillary artery. A single injection of the local an esthetic will be performed without needle repositioning unless paresthesia is elicited
The axillary nerve block is performed from behind the patient with the patient seated. The axillary nerve will be identified within the quadrilateral space by placing high frequency linear probe parallel to the long axis of the humeral shaft. The nerve was identified next to the circumflex artery
Eligibility Criteria
You may qualify if:
- Patients acceptance to share in the study.
- Patients with ASA physical status I-II.
- Obese patients (BMI 30-40 kg/m²) undergoing around and below elbow surgeries under regional anesthesia.
- Patients requiring a single injection infraclavicular retroclavicular brachial plexus block or axillary block for around and below elbow surgeries.
You may not qualify if:
- Patients with a history of allergic reactions or contraindications to local anesthetics.
- Patients with significant comorbidities (e.g., severe cardiovascular, neurological, or musculoskeletal disorders).
- Patients with a history of previous shoulder or clavicle surgery that may distort anatomy and affect the efficacy of the block.
- Pregnant or breastfeeding women.
- Patients with a history of systemic infections or skin infections in the area of the block.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
faculty of medicine,zagazig university Egypt
Zagazig, 44519, Egypt
Study Officials
- STUDY DIRECTOR
Howida A Kamal, MD
faculty of medicine,zagazig university Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant professor of anesthesia and surgical intensive care (Principal Investigator)
Study Record Dates
First Submitted
September 30, 2025
First Posted
October 7, 2025
Study Start
October 15, 2025
Primary Completion
March 15, 2026
Study Completion
April 15, 2026
Last Updated
December 16, 2025
Record last verified: 2025-09